Cargando…
Clozapine treatment and risk of COVID-19
The antipsychotic clozapine is known to have immune-modulating effects. Clozapine treatment has been reported to be associated with increased risk of COVID-19 infection. However, it remains unclear whether this is because of increased testing of this patient group, who are closely monitored. We link...
Autores principales: | Osimo, Emanuele F., Lewis, Jonathan, Cardinal, Rudolf N., Khandaker, Golam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273724/ https://www.ncbi.nlm.nih.gov/pubmed/35815763 http://dx.doi.org/10.1192/bjo.2022.537 |
Ejemplares similares
-
Prevalence and correlates of low-grade systemic inflammation in adult psychiatric inpatients: An electronic health record-based study
por: Osimo, Emanuele F., et al.
Publicado: (2018) -
Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study
por: Wolpe, Noham, et al.
Publicado: (2023) -
Inflammatory and cardiometabolic markers at presentation with first episode psychosis and long-term clinical outcomes: A longitudinal study using electronic health records
por: Osimo, Emanuele F., et al.
Publicado: (2021) -
Longitudinal population subgroups of CRP and risk of depression in the ALSPAC birth cohort
por: Osimo, Emanuele F., et al.
Publicado: (2020) -
Predicting treatment resistance from first-episode psychosis using routinely collected clinical information
por: Osimo, Emanuele F., et al.
Publicado: (2023)